Lies Lahousse

9.3k total citations · 1 hit paper
176 papers, 3.9k citations indexed

About

Lies Lahousse is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lies Lahousse has authored 176 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pulmonary and Respiratory Medicine, 70 papers in Physiology and 40 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lies Lahousse's work include Chronic Obstructive Pulmonary Disease (COPD) Research (65 papers), Asthma and respiratory diseases (48 papers) and Atrial Fibrillation Management and Outcomes (26 papers). Lies Lahousse is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (65 papers), Asthma and respiratory diseases (48 papers) and Atrial Fibrillation Management and Outcomes (26 papers). Lies Lahousse collaborates with scholars based in Belgium, Netherlands and United States. Lies Lahousse's co-authors include Guy Brusselle, Bruno H. Stricker, M. Arfan Ikram, Guy Joos, Oscar H. Franco, Albert Hofman, Natalie Terzikhan, Katia Verhamme, Maxim Grymonprez and Stéphane Steurbaut and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Lies Lahousse

160 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COPD and multimorbidity: recognising and addressing a syndemic occurrence

2023 112 citations Lies Lahousse, Lowie E.G.W. Vanfleteren et al. profile →

Peers

Countries citing papers authored by Lies Lahousse

Since Specialization

Citations

This map shows the geographic impact of Lies Lahousse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lies Lahousse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lies Lahousse more than expected).

Fields of papers citing papers by Lies Lahousse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lies Lahousse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lies Lahousse. The network helps show where Lies Lahousse may publish in the future.

Co-authorship network of co-authors of Lies Lahousse

This figure shows the co-authorship network connecting the top 25 collaborators of Lies Lahousse. A scholar is included among the top collaborators of Lies Lahousse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lies Lahousse. Lies Lahousse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular safety of biologic therapies in patients with severe asthma: a nationwide cohort study in Belgium 2025 ·The Lancet Regional Health - Europe ·(unknown), (unknown), Maxim Grymonprez, Lowie E.G.W. Vanfleteren, Guy Brusselle, Lies Lahousse	2
2	Predictors of mortality and hospitalised exacerbations in obstructive airway diseases 2025 ·ERJ Open Research ·(unknown), (unknown), Maxim Grymonprez, Guy Joos, Lies Lahousse	1
3	Real-life impact of anti-IL5 therapy on exacerbation types in patients with obstructive lung disease 2025 ·BMJ Open Respiratory Research ·Lowie E.G.W. Vanfleteren, (unknown), Lies Lahousse	1
4	Medication adherence to inhalation therapy and the risk of COPD exacerbations: a systematic review with meta-analysis 2024 ·BMJ Open Respiratory Research ·(unknown), (unknown), Maxim Grymonprez, (unknown), Lies Lahousse	3
5	Clinical relevance of lung function trajectory clusters in middle-aged and older adults 2023 ·ERJ Open Research ·(unknown), James C. Ross, Rosa Faner, Michael H. Cho, M. Arfan Ikram, Guy Brusselle, Lies Lahousse	0
6	Do the lockdown-imposed changes in a wastewater treatment plant catchment's socio-demographics impact longitudinal temporal trends in psychoactive pharmaceutical use? 2023 ·The Science of The Total Environment ·Tim Boogaerts, (unknown), Hans De Loof, (unknown), (unknown), (unknown), Jan Saevels, Lies Lahousse, (unknown), (unknown), Bert Aertgeerts, Adrian Covaci, Alexander L.N. van Nuijs	9
7	Oral corticosteroid use and sarcopenia-related traits in older people with chronic airway disease: a population-based study 2023 ·ERJ Open Research ·Elizabeth Benz, Lies Lahousse, (unknown), Sara Wijnant, Maria de Ridder, Fernando Rivadeneira, Guy Brusselle, Bruno H. Stricker	5
8	Impact of triple therapy on mortality in COPD 2023 ·Breathe ·Thibaud Soumagne, M. Zysman, (unknown), Lies Lahousse, Alexander G. Mathioudakis	4
9	Methods to assess COPD medications adherence in healthcare databases: a systematic review 2023 ·European Respiratory Review ·(unknown), (unknown), (unknown), Jennifer K Quint, Katia Verhamme, Lies Lahousse	4
10	Smoking cessation encouragement by community pharmacists. 2023 ·International Journal of Integrated Care ·(unknown), Eline Tommelein, Lies Lahousse	1
11	Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System 2023 ·Pharmacoepidemiology and Drug Safety ·(unknown), (unknown), Jan A. Kors, Erik M. van Mulligen, (unknown), Marcel de Wilde, Lies Lahousse, Johan van der Lei, Peter R. Rijnbeek, Katia Verhamme	1
12	European Respiratory Society statement on frailty in adults with chronic lung disease 2023 ·European Respiratory Journal ·Christian Osadnik, Lisa Jane Brighton, Chris Burtin, Matteo Cesari, Lies Lahousse, William D‐C Man, Alessandra Marengoni, (unknown), Jonathan P. Singer, Lies ter Beek, Ioanna Tsiligianni, János Tamás Varga, (unknown), Matthew Maddocks	32
13	Serum immunoglobulin levels and risk of antibiotic prescription in middle-aged and older individuals: A population-based cohort study 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Virgil A. S. H. Dalm, Layal Chaker, Guy Brusselle, Bruno H. Stricker, Lies Lahousse	0
14	Time series modelling for wastewater-based epidemiology of COVID-19: A nationwide study in 40 wastewater treatment plants of Belgium, February 2021 to June 2022 2023 ·The Science of The Total Environment ·(unknown), (unknown), Raphaël Janssens, (unknown), Bavo Verhaegen, Peter Delputte, Tim Boogaerts, Alexander L.N. van Nuijs, Delphine Brogna, Catherine Linard, Jonathan Marescaux, (unknown), (unknown), Nancy H. C. Roosens, Koenraad Van Hoorde, (unknown), Lies Lahousse	13
15	Building an understanding of goal-oriented care through the experiences of people living with chronic conditions 2022 ·Patient Education and Counseling ·(unknown), (unknown), Dorine Lenoir, An De Sutter, (unknown), Lies Lahousse, Peter Pype, Dominique Van de Velde, Pauline Boeckxstaens, Patricia De Vriendt	5
16	Frailty Transitions in Older Persons With Lung Function Impairment: A Population-Based Study 2022 ·The Journals of Gerontology Series A ·Sara Wijnant, Elizabeth Benz, Annemarie I. Luik, Fernando Rivadeneira, Trudy Voortman, Guy Brusselle, Lies Lahousse	13
17	Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study 2021 ·ERJ Open Research ·Elizabeth Benz, Sara Wijnant, Katerina Trajanoska, (unknown), Emmely W. de Roos, Maria de Ridder, Ross D. Williams, Frank J.A. van Rooij, Katia Verhamme, M. Arfan Ikram, Bruno H. Stricker, Fernando Rivadeneira, Lies Lahousse, Guy Brusselle	42
18	Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies 2021 ·BMJ Open Respiratory Research ·(unknown), (unknown), (unknown), Lies Lahousse	21
19	A pragmatic randomized controlled trial to improve inhaler technique using mHealth 2020 ·Clinical and Translational Allergy ·(unknown), (unknown), (unknown), Lies Lahousse	1
20	Impact of frailty on interpretability of spirometry: The Rotterdam study 2013 ·European Respiratory Journal ·Bastiaan Maes, Lies Lahousse, Daan W. Loth, Vincentius J.A. Verlinden, Gijsbertus Ziere, M. Carola Zillikens, André G. Uitterlinden, Fernando Rivadeneira, Henning Tiemeier, M. Arfan Ikram, G.F. Joos, Albert Hofman, Bruno H. Stricker, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact